Cell-SPECIFIC DNA, RNA and crispr therapies

We are overcoming the biggest challenge for DNA, RNA and CRISPR therapies: Delivering large genetic payloads into the correct cells.

Our pipeline includes therapies for currently incurable rare diseases. Selected industry partners can also license our cell-specific delivery technology.


© 2021 Nuntius Therapeutics.

Nuntius Therapeutics, Inc.

San Francisco, United States

Nuntius Therapeutics Ltd.

London, United Kingdom